Sadia Shafi
NPI: 1013178805
Total Payments
$4,764
2024 Payments
$711.94
Companies
44
Transactions
271
Medicare Patients
8,416
Medicare Billing
$793,856
Payment Breakdown by Category
Food & Beverage$4,652 (97.7%)
Education$74.99 (1.6%)
Other$36.75 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,652 | 268 | 97.7% |
| Education | $74.99 | 1 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36.75 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $816.94 | 53 | $0 (2024) |
| Amgen Inc. | $495.05 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $484.36 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $371.14 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $350.20 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $184.58 | 9 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $165.62 | 9 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $148.64 | 10 | $0 (2020) |
| Novo Nordisk Inc | $140.74 | 7 | $0 (2024) |
| iRhythm Technologies, Inc. | $130.69 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $711.94 | 32 | Amgen Inc. ($107.91) |
| 2023 | $613.47 | 30 | Novartis Pharmaceuticals Corporation ($136.26) |
| 2022 | $317.13 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($71.64) |
| 2021 | $14.65 | 1 | Novartis Pharmaceuticals Corporation ($14.65) |
| 2020 | $237.86 | 16 | Amgen Inc. ($52.70) |
| 2019 | $1,115 | 60 | Amgen Inc. ($105.97) |
| 2018 | $914.33 | 61 | Novartis Pharmaceuticals Corporation ($187.80) |
| 2017 | $838.94 | 53 | Novartis Pharmaceuticals Corporation ($261.67) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology | ||||||
| 09/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Cardiology | ||||||
| 07/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: Cardiovascular | ||||||
| 07/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiology | ||||||
| 07/18/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: NEUROLOGY | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.38 | General |
| 06/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.16 | General |
| 05/15/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Cardiovascular | ||||||
| 05/01/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,281 | 2,860 | $571,888 | $223,302 |
| 2022 | 20 | 2,082 | 2,463 | $454,966 | $182,532 |
| 2021 | 22 | 2,256 | 2,856 | $516,527 | $227,688 |
| 2020 | 21 | 1,797 | 2,117 | $385,825 | $160,333 |
Total Patients
8,416
Total Services
10,296
Medicare Billing
$793,856
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 353 | 483 | $125,580 | $44,819 | 35.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 83 | 83 | $78,269 | $31,013 | 39.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 187 | 188 | $82,720 | $29,494 | 35.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 137 | 140 | $51,940 | $20,723 | 39.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 85 | 86 | $25,500 | $19,874 | 77.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 118 | $42,716 | $16,133 | 37.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $31,914 | $13,535 | 42.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 137 | $27,126 | $13,110 | 48.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 452 | 681 | $37,455 | $7,726 | 20.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 34 | 133 | $11,968 | $5,835 | 48.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 83 | 83 | $12,865 | $4,306 | 33.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 18 | 18 | $6,642 | $3,576 | 53.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $8,878 | $2,942 | 33.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 408 | 437 | $7,429 | $2,660 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,985 | $2,239 | 37.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 17 | 17 | $6,307 | $1,970 | 31.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 36 | 36 | $4,710 | $1,852 | 39.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 33 | 34 | $1,802 | $719.10 | 39.9% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 30 | 31 | $961.00 | $324.26 | 33.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 15 | 15 | $645.00 | $258.15 | 40.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 17 | 17 | $476.00 | $193.80 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 340 | $88,400 | $31,207 | 35.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 160 | 165 | $72,282 | $26,816 | 37.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 165 | 171 | $61,383 | $26,506 | 43.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 56 | 56 | $52,808 | $21,390 | 40.5% |
About Sadia Shafi
Sadia Shafi is a Student in an Organized Health Care Education/Training Program healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013178805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sadia Shafi has received a total of $4,764 in payments from pharmaceutical and medical device companies, with $711.94 received in 2024. These payments were reported across 271 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,652).
As a Medicare-enrolled provider, Shafi has provided services to 8,416 Medicare beneficiaries, totaling 10,296 services with total Medicare billing of $793,856. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Annapolis, MD
- Active Since 06/24/2008
- Last Updated 06/30/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1013178805
Products in Payments
- ENTRESTO (Drug) $705.22
- XARELTO (Drug) $484.36
- ELIQUIS (Drug) $330.71
- BRILINTA (Drug) $252.76
- Repatha (Biological) $196.01
- Corlanor (Drug) $187.12
- LifeVest (Device) $165.62
- NUPLAZID (Drug) $148.64
- LEQVIO (Drug) $111.72
- Aimovig (Biological) $94.14
- JARDIANCE (Drug) $88.11
- OPSUMIT (Drug) $87.67
- MULTAQ (Drug) $85.00
- NUEDEXTA (Drug) $82.19
- ZIO Patch (Device) $77.26
- PRALUENT (Drug) $75.39
- Rybelsus (Drug) $68.05
- FARXIGA (Drug) $66.28
- CAMZYOS (Drug) $63.32
- Ozempic (Drug) $58.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Annapolis
Dr. Igor Belyansky, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $645,870
Student in an Organized Health Care Education/Training Program $645,870
Juddson Chason, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $20,881
Student in an Organized Health Care Education/Training Program $20,881
Mary Holthaus, Pa, PA
Student in an Organized Health Care Education/Training Program — Payments: $11,376
Student in an Organized Health Care Education/Training Program $11,376
Samip Patel, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $10,231
Student in an Organized Health Care Education/Training Program $10,231
Kari Bailey, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,236
Student in an Organized Health Care Education/Training Program $6,236
Christopher Jones, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,947
Student in an Organized Health Care Education/Training Program $3,947